Search

everythinglearnresearchcommunity

for

Search:↓

Actinic keratosis is more common in older men with certain genetic traits, but smoking seems to reduce its odds.

Too much IKZF1 and Ikaros protein may cause alopecia areata.

AGA linked to inflammation, stress, fibrosis, and disturbed hair follicle stem cells.

Ac-GFFY-IGF peptide is a promising, safe, and effective treatment for hair loss, better than current options.

Testosterone causes hair loss in AGA mice, which are good for testing baldness treatments, and both minoxidil and cyproterone acetate can prevent this hair loss.

ChatGPT 4.0 and Gemini 1.5 Flash are effective for educating patients about androgenetic alopecia, while Deepseek R1 is less reliable.

Androgenetic alopecia is a common type of hair loss in men and women, caused by a testosterone byproduct affecting hair follicles, with sensitivity determined by genetics.

DMG-Na may help reduce hair loss and improve hair growth, but more research is needed.

Stopping the antidepressant agomelatine improved hair loss in a patient.

Microneedling can weaken hair in some AGA patients.

Panax ginseng extract may help prevent hair loss caused by DKK-1.

Autologous micrografting via the Rigenera® system shows promise in improving hair loss treatment.

There is no significant link between the MMP-1 rs1799750 polymorphism and androgenetic alopecia in the Indonesian population.

New treatments for common hair loss are needed.

Practitioners treating hair loss need better education and resources to overcome challenges like commercial bias and ethical dilemmas.

The conclusion is that more women in their forties are getting AGA and stress is linked to AGA in both men and women.

EX104 shows promise in treating hair loss by promoting hair growth and improving scalp health.

Aire mutation reduces alopecia areata, while Notch4 mutation prevents it in mice.

Effective treatments for hair loss include minoxidil, 5α-reductase inhibitors, and personalized combination therapies.

Hair loss affects self-esteem; patients seek effective, low side-effect treatments.

Androgenetic alopecia causes hair loss, affects men more severely, and treatments are only temporarily effective.

AGA, a common hair loss, is caused by genetics, hormones, age, and environmental factors.

The treatment showed promising results in improving advanced-stage hair loss.

IGFBP-rP1 could be a new treatment for a common type of hair loss.

AGA causes hair loss through follicle miniaturization and hair cycle changes; regrowth depends on anagen initiation in kenogen follicles.

The study suggests that a specific type of immune cell, memory-like NK cells, may increase during active hair loss in Alopecia areata.

Overexpression of IKZF1 and Ikaros causes hair loss in mice similar to alopecia areata.

Injections of special skin cells showed potential in treating hair loss, with some participants experiencing increased hair density.

A testosterone-induced hair loss model in mice was successfully created for future research and treatment testing.